Advanced search×

Renal improvement in myeloma with bortezomib plus plasma exchange.

Brian L BL Burnette, Nelson N Leung, and S Vincent SV Rajkumar

N Engl J Med 364(24):2365-6 (2011) PMID 21675906

DOI: 10.1056/NEJMc1101834
Version: za2963e q8za6 q8zb9 q8zcb q8zd2 q8ze4 q8zf4 q8zg4
View PDF

Similar articles you may find interesting…

  1. BRAF mutations in hairy-cell leukemia.
    Enrico E Tiacci, Vladimir V Trifonov, ... Brunangelo B Falini

    N Engl J Med 364(24):2305-15 (2011) PMID 21663470

    Hairy-cell leukemia (HCL) is a distinct disease entity that is characterized by an indolent course, marked splenomegaly, progressive pancytopenia in many cases, and rare circulating tumor cells, usually with no lymphadenopathy.1 The bone marrow, spleen, and liver are characteristically infiltrated by...
  2. Treatment of multiple myeloma.
    S Vincent SV Rajkumar

    Nat Rev Clin Oncol 8(8):479-91 (2011) PMID 21522124

  3. Managed competition for Medicare? Sobering lessons from The Netherlands.
    Kieke G H KG Okma, Theodore R TR Marmor, and Jonathan J Oberlander

    N Engl J Med 365(4):287-9 (2011) PMID 21675914